IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is a lethal condition, and therefore novel approaches are needed. Monocyte-derived dendritic cells (mDCs) pulsed with tumor antigens, as professional antigen-presenting cells, are a promising strategy for immunotherapy of invasive brain tumors. MET...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Madrid, Andres Morales La, Mora, Jaume, Cruz, Ofelia, Lopez, Vicente Santa-Maria, Perez-Jaume, Sara, Guillen, Antonio, Paco, Sonia, Carcaboso, Angel M, Puerta, Patricia, Salvador, Noelia, Juan, Manuel, Benitez-Ribas, Daniel, Cabezon, Raquel, Flórez-Grau, Georgina, Molero, Mari Carmen
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715823/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.378
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares